Company overview

As a member of ONO Group, Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.
Founded in 2003
Waltham, Massachusetts, USA
511 employees (17 in marketing)
92% recommend to a friend
89% positive business outlook

Salaries

Typical salary range

$165,500 – $228,500

/ yr

Help build salary transparency at Deciphera Pharmaceuticals

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount +14.3% year over year

Funding

Total funding

$1B

Last raise

$125M

Post IPO Equity, 3 years ago

Funding history

Jan 2023

Post IPO Equity Deciphera Pharmaceuticals · $125M

Apr 2022

Post IPO Equity Deciphera Pharmaceuticals · $172.5M

Aug 2019

Post IPO Equity Deciphera Pharmaceuticals · $400M

Jun 2018

Post IPO Equity Deciphera Pharmaceuticals · $172M

Jun 2017

Series C Deciphera Pharmaceuticals · $52M

Jan 2016

Series B Deciphera Pharmaceuticals · $15M

Audience

Monthly website visitors
9.9K
Month over month-18.1%
Quarter over quarter-35.9%
Top sourceSearch (47.4%)
Ad budget per month$0.0
Average search rank41.3
Traffic source mix
Search
47.4%
Direct
40.3%
Social
5.4%
Referral
5.4%
Paid referral
1.3%

LinkedIn followers

Follower count and growth

Total followers

65.7K

12-mo growth

+31.6%

Monthly growth

+1.8%

News

Links